Brief: Zhaoke Ophthalmology says Atropine Sulfate Eye Drops Accepted For Evaluation By Australia's TGA
Jan 13 (Reuters) - Zhaoke Ophthalmology Ltd 6622.HK: ATROPINE SULFATE EYE DROPS ACCEPTED FOR EVALUATION BY THERAPEUTIC GOODS ADMINISTRATION OF AUSTRALIA Further company coverage: 6622.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zhaoke Ophthalmology
See all newsBrief: Zhaoke Ophthalmology Says Its Facility In Guangzhou Obtains GMP Certification From Australia's TGA
China's Zhaoke Ophthalmology H1 revenue rises
Brief: Zhaoke Ophthalmology Says Yuvezzitm Approved By Macau Pharmaceutical Administration Bureau
Brief: Zhaoke Ophthalmology Enters Into Definitive Agreement For Acquisition Of Global Rights To NVK002
Brief: Zhaoke Ophthalmology Says Yuvezzitm Approved For Use At Boao Super Hospital